EDMA (original) (raw)

About DBpedia

3,4-Ethylenedioxy-N-methylamphetamine (EDMA) is an entactogen drug of the methamphetamine class. It is an analogue of MDMA where the methylenedioxy ring has been replaced by an ethylenedioxy ring. EDMA was first synthesized by Alexander Shulgin. In his book PiHKAL, the dosage is listed as 150–250 mg, and the duration listed as 3–5 hours. According to Shulgin, EDMA produces a bare threshold consisting of paresthesia, nystagmus, and hypnogogic imagery, with few to no other effects. Scientific research has demonstrated that EDMA acts as a non-neurotoxic serotonin releasing agent with moderately diminished potency relative to MDMA, and with negligible effects on dopamine release.

thumbnail

Property Value
dbo:abstract 3,4-Ethylenedioxy-N-methylamphetamine (EDMA) is an entactogen drug of the methamphetamine class. It is an analogue of MDMA where the methylenedioxy ring has been replaced by an ethylenedioxy ring. EDMA was first synthesized by Alexander Shulgin. In his book PiHKAL, the dosage is listed as 150–250 mg, and the duration listed as 3–5 hours. According to Shulgin, EDMA produces a bare threshold consisting of paresthesia, nystagmus, and hypnogogic imagery, with few to no other effects. Scientific research has demonstrated that EDMA acts as a non-neurotoxic serotonin releasing agent with moderately diminished potency relative to MDMA, and with negligible effects on dopamine release. (en) エチレンジオキシメタンフェタミン (3,4-Ethylenedioxy-N-methylamphetamine、EDMA) はアンフェタミン系のエンタクトゲンである。メチレンジオキシメタンフェタミン (MDMA) のアナログで、メチレンジオキシ環がエチレンジオキシ環に置き換わっている。アレクサンダー・シュルギンによって初めて合成された。彼の著書 PiHKAL では、投与量は150-250 mg、持続時間は3-5時間とされている。シュルギンによると、EDMAは、痺れ、、入眠時心像等の影響があり、その他の効果はほぼない。EDMAはMDMAと比べて作用が弱く、ドーパミン放出にはほとんど影響を与えない非神経毒性として作用することが示されている。これはシュルギンの150-250 mgの投与量の報告に基づいており、より大量の投与ではより作用が強い可能性がある。 (ja)
dbo:casNumber 133787-66-3
dbo:fdaUniiCode UJ7UU2C6E6
dbo:pubchem 24257269
dbo:thumbnail wiki-commons:Special:FilePath/Ethylenedioxymethamphetamine.svg?width=300
dbo:wikiPageExternalLink http://pihkal.info/read.php%3Fdomain=pk&id=110 http://www.erowid.org/library/books_online/pihkal/pihkal110.shtml
dbo:wikiPageID 10115053 (xsd:integer)
dbo:wikiPageLength 3987 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID 1108264764 (xsd:integer)
dbo:wikiPageWikiLink dbr:Potency_(pharmacology) dbr:Methylenedioxy dbr:Mouth dbr:Structural_analog dbr:Substituted_amphetamine dbr:Nystagmus dbc:Designer_drugs dbc:Serotonin_releasing_agents dbr:Functional_group dbr:Drug dbr:Alexander_Shulgin dbr:Paresthesia dbc:Methamphetamines dbc:Substituted_amphetamines dbc:Benzodioxans dbr:Dopamine dbr:Entactogen dbr:Mental_imagery dbr:Neurotoxic dbr:Serotonin_releasing_agent dbr:Ethylenedioxy dbr:PiHKAL dbr:Hypnogogic dbr:3,4-methylenedioxy-N-methylamphetamine
dbp:atcPrefix none (en)
dbp:c 12 (xsd:integer)
dbp:casNumber 133787 (xsd:integer)
dbp:chemspiderid 23553090 (xsd:integer)
dbp:h 17 (xsd:integer)
dbp:iupacName 1 (xsd:integer)
dbp:legalCa Schedule III (en)
dbp:legalDe NpSG (en)
dbp:legalUk Class B (en)
dbp:n 1 (xsd:integer)
dbp:o 2 (xsd:integer)
dbp:pubchem 24257269 (xsd:integer)
dbp:routesOfAdministration dbr:Mouth
dbp:smiles CCNC (en)
dbp:stdinchi 1 (xsd:integer)
dbp:stdinchikey UJKWLAZYSLJTKA-UHFFFAOYSA-N (en)
dbp:unii UJ7UU2C6E6 (en)
dbp:verifiedrevid 443531339 (xsd:integer)
dbp:watchedfields changed (en)
dbp:wikiPageUsesTemplate dbt:About dbt:Drugbox dbt:Entactogens dbt:Monoamine_releasing_agents dbt:Phenethylamines dbt:Reflist dbt:Short_description dbt:Cascite dbt:Chemspidercite dbt:Fdacite dbt:Stdinchicite
dcterms:subject dbc:Designer_drugs dbc:Serotonin_releasing_agents dbc:Methamphetamines dbc:Substituted_amphetamines dbc:Benzodioxans
gold:hypernym dbr:Drug
rdf:type owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 yago:WikicatAmphetamines yago:Agent114778436 yago:Amphetamine102704153 yago:CausalAgent100007347 yago:Drug103247620 yago:DrugOfAbuse103248958 yago:Matter100020827 yago:PhysicalEntity100001930 dbo:Drug yago:Stimulant104320126 yago:Substance100020090 umbel-rc:DrugProduct
rdfs:comment 3,4-Ethylenedioxy-N-methylamphetamine (EDMA) is an entactogen drug of the methamphetamine class. It is an analogue of MDMA where the methylenedioxy ring has been replaced by an ethylenedioxy ring. EDMA was first synthesized by Alexander Shulgin. In his book PiHKAL, the dosage is listed as 150–250 mg, and the duration listed as 3–5 hours. According to Shulgin, EDMA produces a bare threshold consisting of paresthesia, nystagmus, and hypnogogic imagery, with few to no other effects. Scientific research has demonstrated that EDMA acts as a non-neurotoxic serotonin releasing agent with moderately diminished potency relative to MDMA, and with negligible effects on dopamine release. (en) エチレンジオキシメタンフェタミン (3,4-Ethylenedioxy-N-methylamphetamine、EDMA) はアンフェタミン系のエンタクトゲンである。メチレンジオキシメタンフェタミン (MDMA) のアナログで、メチレンジオキシ環がエチレンジオキシ環に置き換わっている。アレクサンダー・シュルギンによって初めて合成された。彼の著書 PiHKAL では、投与量は150-250 mg、持続時間は3-5時間とされている。シュルギンによると、EDMAは、痺れ、、入眠時心像等の影響があり、その他の効果はほぼない。EDMAはMDMAと比べて作用が弱く、ドーパミン放出にはほとんど影響を与えない非神経毒性として作用することが示されている。これはシュルギンの150-250 mgの投与量の報告に基づいており、より大量の投与ではより作用が強い可能性がある。 (ja)
rdfs:label EDMA (en) エチレンジオキシメタンフェタミン (ja)
owl:sameAs freebase:EDMA http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB01454 http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB01566 yago-res:EDMA wikidata:EDMA dbpedia-ja:EDMA dbpedia-sh:EDMA dbpedia-sr:EDMA https://global.dbpedia.org/id/4ig3H
prov:wasDerivedFrom wikipedia-en:EDMA?oldid=1108264764&ns=0
foaf:depiction wiki-commons:Special:FilePath/Ethylenedioxymethamphetamine.svg
foaf:isPrimaryTopicOf wikipedia-en:EDMA
is dbo:wikiPageDisambiguates of dbr:EDMA_(disambiguation)
is dbo:wikiPageRedirects of dbr:3,4-EDMA dbr:3,4-Ethylenedioxy-N-methamphetamine dbr:3,4-Ethylenedioxy-N-methylamphetamine dbr:3,4-Ethylenedioxymethamphetamine dbr:3,4-Ethylenedioxymethylamphetamine dbr:3,4-ethylenedioxy-N-methamphetamine dbr:3,4-ethylenedioxy-N-methylamphetamine dbr:3,4-ethylenedioxymethamphetamine dbr:3,4-ethylenedioxymethylamphetamine dbr:Ethylenedioxymethamphetamine dbr:Ethylenedioxymethylamphetamine
is dbo:wikiPageWikiLink of dbr:List_of_designer_drugs dbr:C12H17NO2 dbr:Substituted_amphetamine dbr:List_of_psychedelic_drugs dbr:MDMA dbr:3,4-Ethylidenedioxyamphetamine dbr:EDMA_(disambiguation) dbr:TH-PVP dbr:MDMC_(disambiguation) dbr:MedTech_Europe dbr:Substituted_methylenedioxyphenethylamine dbr:3,4-EDMA dbr:3,4-Ethylenedioxy-N-methamphetamine dbr:3,4-Ethylenedioxy-N-methylamphetamine dbr:3,4-Ethylenedioxymethamphetamine dbr:3,4-Ethylenedioxymethylamphetamine dbr:3,4-ethylenedioxy-N-methamphetamine dbr:3,4-ethylenedioxy-N-methylamphetamine dbr:3,4-ethylenedioxymethamphetamine dbr:3,4-ethylenedioxymethylamphetamine dbr:Ethylenedioxymethamphetamine dbr:Ethylenedioxymethylamphetamine
is foaf:primaryTopic of wikipedia-en:EDMA